Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mesenchymal-epithelial transition factor (MET) immunoreactivity in positive sentinel nodes from patients with melanoma.
Mulder EEAP, Verver D, van der Klok T, de Wijs CJ, van den Bosch TPP, De Herdt MJ, van der Steen B, Verhoef C, van der Veldt AAM, Grünhagen DJ, Koljenovic S. Mulder EEAP, et al. Among authors: van der klok t, van der veldt aam, van den bosch tpp, van der steen b. Ann Diagn Pathol. 2022 Jun;58:151909. doi: 10.1016/j.anndiagpath.2022.151909. Epub 2022 Feb 7. Ann Diagn Pathol. 2022. PMID: 35151198 Free article.
Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BWEM, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Eggermont AMM, Verhoef C, Grünhagen DJ. Verver D, et al. Among authors: van klaveren d, van akkooi acj, van der veldt aam, van leeuwen bl. Eur J Cancer. 2018 Jun;96:25-33. doi: 10.1016/j.ejca.2018.02.022. Epub 2018 Apr 13. Eur J Cancer. 2018. PMID: 29660597
The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
Verver D, Rekkas A, Garbe C, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BWEM, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Stadler R, Eggermont AMM, Verhoef C, Leiter U, Grünhagen DJ. Verver D, et al. Among authors: van klaveren d, van akkooi acj, van der veldt aam, van leeuwen bl. Eur J Cancer. 2020 Jul;134:9-18. doi: 10.1016/j.ejca.2020.04.022. Epub 2020 May 23. Eur J Cancer. 2020. PMID: 32454396 Free article.
Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma.
Mulder EEAP, Dwarkasing JT, Tempel D, van der Spek A, Bosman L, Verver D, Mooyaart AL, van der Veldt AAM, Verhoef C, Nijsten TEC, Grunhagen DJ, Hollestein LM. Mulder EEAP, et al. Among authors: van der spek a, van der veldt aam. Br J Dermatol. 2021 May;184(5):944-951. doi: 10.1111/bjd.19499. Epub 2020 Nov 2. Br J Dermatol. 2021. PMID: 32844403 Free PMC article.
An Overview of Liver Directed Locoregional Therapies.
Höppener DJ, Grünhagen DJ, Eggermont AMM, van der Veldt AAM, Verhoef C. Höppener DJ, et al. Among authors: van der veldt aam. Surg Oncol Clin N Am. 2021 Jan;30(1):103-123. doi: 10.1016/j.soc.2020.09.001. Surg Oncol Clin N Am. 2021. PMID: 33220800 Free article. Review.
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Mulder EEAP, de Joode K, Litière S, Ten Tije AJ, Suijkerbuijk KPM, Boers-Sonderen MJ, Hospers GAP, de Groot JWB, van den Eertwegh AJM, Aarts MJB, Piersma D, van Rijn RS, Kapiteijn E, Vreugdenhil G, van den Berkmortel FWPJ, Hoop EO, Franken MG, Ryll B, Rutkowski P, Sleijfer S, Haanen JBAG, van der Veldt AAM. Mulder EEAP, et al. Among authors: van den eertwegh ajm, van der veldt aam, van den berkmortel fwpj, van rijn rs. BMC Cancer. 2021 Mar 25;21(1):323. doi: 10.1186/s12885-021-08018-w. BMC Cancer. 2021. PMID: 33765967 Free PMC article.
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
Verver D, Grünhagen DJ, van Akkooi ACJ, Aarts MJB, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, Boers-Sonderen MJ, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, Suijkerbuijk KPM, Tije AJT, Vreugdenhil G, Verhoef C, van der Veldt AAM. Verver D, et al. Among authors: van akkooi acj, van den eertwegh ajm, van der veldt aam, van den berkmortel fwpj, van rijn rs. Cancer Immunol Immunother. 2021 Nov;70(11):3123-3135. doi: 10.1007/s00262-021-02871-1. Epub 2021 Mar 27. Cancer Immunol Immunother. 2021. PMID: 33774697 Free PMC article.
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
Mulder EEAP, Stahlie EHA, Verver D, Lemstra C, Been LB, Mooyaart AL, Brabander T, Vegt E, Verburg FA, van der Veldt AAM, Verhoef C, van Akkooi ACJ, Grünhagen DJ. Mulder EEAP, et al. Among authors: van akkooi acj, van der veldt aam. J Surg Oncol. 2021 Dec;124(7):1161-1165. doi: 10.1002/jso.26607. Epub 2021 Jul 8. J Surg Oncol. 2021. PMID: 34235758 Free PMC article.
204 results